Hagens Berman & Erasca

Hagens Berman: Hagens Berman is a shareholder rights law firm investigating and filing class action lawsuits against Erasca for alleged securities law violations.

Erasca: Erasca is the defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its drug candidate ERAS-0015, patent infringement claims, and a patient death during clinical trials. This has led to a significant drop in its stock price and market capitalization.

Hagens Berman: Hagens Berman is investigating the securities fraud claims and representing investors. The firm is actively seeking lead plaintiff role.

Erasca: Erasca is the defendant in the securities class action, accused of misleading investors about ERAS-0015. Its stock collapsed over 45% following disclosures of patent disputes and a patient death, erasing billions in market value.